| Description of established cell lines | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cell line | Patient gender | Cell source | Histology | Grade | Age (years) | |||||||||
| A818-1 | Female | Ascites | Moderately differentiated, ductal adenocarcinoma | G2 | 75 | |||||||||
| AsPC-1 | Female | Ascites | Well-moderately differentiated, ductal adenocarcinoma | G2 | 62 | |||||||||
| BxPC-3 | Female | Primary tumour | Moderately differentiated, ductal adenocarcinoma | G2 | 61 | |||||||||
| CFPAC-1 | Male | Liver metastasis | Well differentiated, ductal adenocarcinoma; cystic fibrosis | - | 26 | |||||||||
| Colo357 | - | Lymph node metastasis | Well differentiated, ductal adenocarcinoma | G2 | - | |||||||||
| MIA PaCa-2 | Male | Primary tumour | Poor-moderately differentiated, ductal carcinoma | G3 | 65 | |||||||||
| PaCa-44 | Female | Primary tumour | Moderately differentiated, ductal adenocarcinoma | G2 | 44 | |||||||||
| PANC-1 | Male | Primary tumour | Poorly differentiated, ductal epithelioid carcinoma | G3 | 56 | |||||||||
| Pt45P1 | - | Primary tumour | Moderately differentiated, ductal adenocarcinoma | G3 | - | |||||||||
| SK-PC-1 | Male | Primary tumour | Well differentiated, ductal carcinoma | - | - | |||||||||
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.